Shanghai Model Organisms Center, Inc. (SHA:688265)

Market Cap	3.12B +51.6%
Revenue (ttm)	421.26M +10.5%
Net Income	32.43M +399.3%
EPS	0.43 +437.5%
Shares Out	75.62M
PE Ratio	96.05
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	481,277
Average Volume	529,906
Open	40.41
Previous Close	40.91
Day's Range	40.41 - 41.74
52-Week Range	21.78 - 72.72
Beta	0.42
RSI	43.16
Earnings Date	Apr 27, 2026

About SHA:688265

Shanghai Model Organisms Center, Inc. engages research and development, production, sale, and related technical services of genetically modified animal models. The company uses model organisms, such as mice, rats, zebrafish, and nematodes as carriers which uses gene editing technology to introduce or delete target DNA fragments. It offers toolbox of mice; disease mice, such as rare, infectious, and nervous system diseases, cardio-metabolic, autoimmune, and spontaneous tumor; and target humanized knockins, which includes tumor targets, immune ch...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2000
• Employees: 749
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688265

Financial Performance

In 2025, SHA:688265's revenue was 421.26 million, an increase of 10.50% compared to the previous year's 381.24 million. Earnings were 32.43 million, an increase of 399.29%.